Opinion
India Must Prioritise Prevention Over Management in Genetic Diseases
Arijit Mukhopadhyay, University of Salford, UK; Dipanjana Datta, Organisation for Rare Disease, India
27 Apr 2026
Department of Biotechnology DBT
Showing 1-8 of 8 articles
Policy Bites
India’s Bioeconomy Reaches $195 Billion Milestone
19 Mar 2026
Opinion
India Must Integrate Genetic Screening for Irreversible Blindness Prevention
Arijit Mukhopadhyay, University of Salford, UK; Nishtha Bhargava, Plaksha University, India
18 Mar 2026
Policy Bites
India Entering the Era of Precision Medicine and Biomanufacturing
14 Mar 2026
Policy Bites
SUJVIKA: AI-Driven Biotech Innovation Portal (DBT 40th Foundation Day)
25 Feb 2026
Opinion
When Breakthrough Cancer Care Meets India’s Policy Reality
Arpita Mukherjee, Independent immunologist and Biochemist
25 Feb 2026
Policy Bites
Cabinet Approves Phase III of Biomedical Research Career Programme to Train 2,000+ Scientists
01 Oct 2025
Opinion
From API to IP: Why India Must Back Medicinal Chemistry as a Strategic Service
Rishikesh Narayan, IIT Goa
02 Sept 2025
Rethinking Public Policy Through Insight | Inquiry | Impact
Opinion • Grassroots Voices • Policymakers Perspectives • Expert Analysis • Policy Briefs
An independent platform that connects research and public policy through clear, evidence-based communication, guided by an apolitical, non-partisan ethos.